Efficacy and Safety of Calcium Hydroxylapatite for Nasal Augmentation: A 12‐Month Prospective Study in a Chinese Population
Key Points
To evaluate the efficacy and safety of calcium hydroxylapatite for nasal augmentation over 12 months.
Conducted a 12-month prospective study
Involved calcium hydroxylapatite injections
Assessed patient satisfaction and safety outcomes
CaHA injections resulted in significant volumetric improvement
High levels of patient satisfaction reported
No major safety concerns observed throughout the study period
Abstract
CaHA injection is an effective and safe treatment for nasal augmentation, providing durable volumetric improvement and high patient satisfaction over 12 months.